This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma
Blood Cancer Journal Open Access 05 December 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Coffey MC, Strong JE, Forsyth PA, Lee PW . Reovirus therapy of tumors with activated Ras pathway. Science 1998; 282: 1332–1334.
Strong JE, Coffey MC, Tang D, Sabinin P, Lee PW . The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J 1998; 17: 3351–3362.
Jainchill JL, Aaronson SA, Todaro GJ . Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J Virol 1969; 4: 549–553.
Hull RN, Cherry WR, Johnson IS . The adaptation and maintenance of mammalian cells to continuous growth in tissue culture. Anat Rec 1956; 124: 490–499.
Stanford KK, Etrie WR, Likely GD . The growth in vitro of single isolated tissue cells. J Natl Cancer Inst 1948; 9: 229–246.
Song LT, Gelman I, Holland JF, Ohnuma T . Study of reovirus-induced cytopathic effect (CPE), ras, double-stranded RNA-activated protein kinase (PKR) and eIF2α in human tumor cell lines. Proc Am Assoc Cancer Res 2000; 41: 350.
van Houdt WJ, Smakman N, van den Wollenberg DJ, Emmink BL, Veenendaal LM, van Diest PJ et al. Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles. Cancer Gene Ther 2008; 15: 284–292.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Song, L., Ohnuma, T., Gelman, I. et al. Reovirus infection of cancer cells is not due to activated Ras pathway. Cancer Gene Ther 16, 382 (2009). https://doi.org/10.1038/cgt.2008.84
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2008.84
This article is cited by
-
Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma
Blood Cancer Journal (2017)
-
Activity levels of cathepsins B and L in tumor cells are a biomarker for efficacy of reovirus-mediated tumor cell killing
Cancer Gene Therapy (2015)
-
Activated Ras signaling significantly enhances reovirus replication and spread
Cancer Gene Therapy (2010)
-
The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status
Oncogene (2010)